Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
23.02
-1.33 (-5.46%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Denali Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $35 → $36 | Buy | Maintains | $35 → $36 | +56.39% | Jul 23, 2026 |
Unknown Analyst Goldman Sachs No rating | Goldman Sachs | Buy Maintains $41 | Buy | Maintains | $41 | +78.11% | Jul 21, 2026 |
| Deutsche Bank | Deutsche Bank | Buy Reiterates $31 → $35 | Buy | Reiterates | $31 → $35 | +52.04% | Jul 16, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $31 | Buy | Reiterates | $31 | +34.67% | Jul 15, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $40 | Buy | Maintains | $40 | +73.76% | Jul 13, 2026 |
| Wedbush | Wedbush | Buy Maintains $20 → $26 | Buy | Maintains | $20 → $26 | +12.95% | Jul 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $42 | Buy | Reiterates | $42 | +82.45% | Jul 13, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Initiates $29 | Buy | Initiates | $29 | +25.98% | Jul 13, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.